Premium
Prophylaxis versus Preemptive Protocols for CMV: Do They Impact Graft Survival?
Author(s) -
Miller G. G.,
Kaplan B.
Publication year - 2008
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2008.02181.x
Subject(s) - medicine , randomized controlled trial , intensive care medicine , kidney transplantation , surgery , transplantation
Debate regarding prophylaxis versus preemptive therapy for CMV infection and disease remains contentious. In this issue, Kliem and colleagues report long term results of a large, randomized, control trial comparing these two approaches in kidney transplant recipients. See also article by Kliem et al in this issue on page 975.